Find Academic Supervisors

• Pediatric Infectious Diseases
• Immunology
• Tuberculosis (TB) Research
• +5 more

Elizabeth Whittaker is a Professor of Practice in Paediatric Infectious Diseases and Immunology at Imperial College London's Faculty of Medicine, with clinical roles as a Consultant in Paediatric Infectious Diseases at St Mary's Hospital. She leads research and clinical initiatives in high-consequence infectious diseases (HCIDs), paediatric TB, and post-COVID-19 conditions. Key roles include National Clinical Lead for HCIDs in children (NHSE), Director of Research at West London Children's Healthcare (WLCH), and co-lead for HCID at Imperial College Healthcare NHS Trust. Affiliations: Centre for Paediatrics and Child Health (PaeCH), Vaccine Research Network, British Paediatric Allergy Infection and Immunity Group (BPAIIG), and PTBNET. Educations: MB BAO BCH (Trinity College Dublin, 2002), PhD in Immune responses to mycobacteria (Imperial College London, 2013), DTM&H (Gorgas Course, 2009). Her research focuses on infant immune development, TB susceptibility, and vaccine hesitancy, with emphasis on global collaboration. She leads projects like the Teen TB cohort study and contributes to WHO guidelines on paediatric TB. Her work addresses viral co-infections, genetic predisposition to severe infections, and long-term outcomes of emerging diseases like monkeypox and MIS-C. Publications highlight her expertise in post-COVID-19 syndrome, HCID management, and vaccination policy. Awards include the Bruno Orsi Medal for research excellence. She chairs national committees on TB, HCIDs, and vaccine hesitancy, advocating for integrated clinical-research pathways in child health. Grants & Funding: Wellcome Trust (PhD), multiple NHS research grants, and international collaborations through the IMPRINT and INVAR networks. Labs/Teams: Leads the Imperial College Paediatric Infectious Diseases Research Group and collaborates with SATVI (South Africa) on TB research.

Lukáš KoberView profile

Assistant Professor

• Public Health
• Nursing
• Infectious Disease Control
• +3 more

PhDr. Lukáš Kober PhD., MPH is an Assistant Professor at the Department of Nursing, Faculty of Health, Catholic University in Ružomberok. He also serves as Director of the Slovak Chamber of Nurses and Midwives (SKSaPA) Office since 2020 and is a member of SKSaPA's Council and Presidium. His career spans nursing practice, academic roles, and public health advocacy. Education: Holds a PhD in Nursing, MPH in Public Health Management, and multiple specialized certifications from institutions like Trnava University and Slovak Medical University. Employment History: Over 15 years of experience including roles as Advanced Practice Registered Nurse at the National Institute of Tuberculosis (2004–2020), professional representative for Home Nursing Agencies, and lecturer in nursing education. Research interests focus on tuberculosis epidemiology, public health policy, infection control, and ethical aspects of nursing practice. He has led projects developing textbooks on infection prevention and rehabilitation procedures post-surgery. His work emphasizes healthcare workforce well-being and pandemic preparedness. Notable publications include studies on tuberculosis trends in Slovakia, nurse workload management during the pandemic, and ethical frameworks in palliative care. Awards include the prestigious 'White Heart' recognition for nursing excellence in 2016 and 2018. Current projects involve advancing nursing education standards and advocating for policies addressing healthcare worker mental health. He is actively involved in editorial roles for nursing journals and national health working groups.

Gail MatthewsView profile

Professor

• Infectious Diseases
• HIV/AIDS
• Viral Hepatitis
• +5 more

Professor Gail Matthews is a leading Infectious Diseases Physician at The Kirby Institute , University of New South Wales, and Head of Infectious Diseases at St Vincent’s Hospital, Sydney . As a UNSW Scientia Fellow and NHMRC Career Development Fellow, her work focuses on HIV/viral hepatitis co-infection and long-term sequelae of COVID-19 . Research Interests : HIV, hepatitis B/C, antiviral resistance, clinical trials, immunology Awards : NHMRC Career Development Fellowships (Level 1, 2013; Level 2, 2019), UNSW Scientia Fellow (2019) Publications : Over 326 journal articles on topics including HCV reinfection , HIV/HBV coinfection , long-term SARS-CoV-2 outcomes , and infections in people who inject drugs . Email : gmatthews@kirby.unsw.edu.au

• Infectious Diseases
• Epidemiology
• Public Health
• +7 more

Dr. Win Min Han is an infectious disease researcher at the University of New South Wales' Kirby Institute, with additional affiliations as an Investigator with the AIDS Clinical Trial Group Network and Affiliated Researcher at Chulalongkorn University, Thailand. He holds MD, MSc, and PhD qualifications with specialized training in clinical epidemiology and virology. His research focuses on HIV-related comorbidities in aging populations, viral hepatitis co-infections, and epidemiological patterns of infectious diseases in vulnerable groups. Primary interests include: Pathophysiology of aging with HIV Clinical trial design for co-infections Cancer epidemiology in immunocompromised patients Metabolic complications of long-term ART Public health interventions for key populations Publication analysis reveals consistent focus on longitudinal outcomes of HIV management, with recent work emphasizing geriatric syndromes, metabolic complications, and innovative treatment monitoring approaches. His 60+ publications demonstrate methodological expertise in cohort studies, clinical trials, and predictive modeling. Awards & Honors: 2024: IAS/ANRS Lange/van Tongeren Prize, CROI New Investigator Scholarship 2023: ACTG's International HIV Investigator Mentorship, CROI Scholarship 2021: APACC Young Investigator Scholarship 2020: AIDS 2020 International Scholarship 2019: Scientia PhD Scholarship (2019-2023) 2018: Multiple conference scholarships including CROI and International AIDS Conference 2017: Triple scholarships from International AIDS Society As an active member of the AIDS Clinical Trial Group Network, he contributes to multicenter studies on HIV comorbidities. His international collaborations span Thailand, Australia, and global research consortia.

Benjamin HegartyView profile

Research Fellow

• Medical Anthropology
• Gender and Sexuality Studies
• Global Health
• +3 more

Benjamin Hegarty is a Senior Research Fellow in the Asia and Pacific Health Program at the Kirby Institute, UNSW Sydney, and a Research Affiliate at the School of Anthropology and Museum Ethnography, University of Oxford. He holds a PhD from the Australian National University (ANU), an MA from Monash University, and a BA from Griffith University. His research bridges medical anthropology, transgender studies, and queer theory, focusing on health inequities and gender norms, particularly in Indonesia and Papua New Guinea. He leads projects on transgender rights, HIV/AIDS policy, and the intersection of health and human rights for marginalized populations. Key research interests include the anthropology of technology, gender citizenship, and the globalization of transgender knowledge. Notable achievements include authoring The Made-Up State: Technology, Trans Femininity, and Citizenship in Indonesia (2022), which won the 2023 Anne Bolin and Gilbert Herdt Book Prize. He has also received the 2018 Australian Anthropological Society PhD Thesis Prize and ANU Gender Institute recognition. Current projects include a French Institutes for Advanced Studies Fellowship (2024–2025) exploring viral symbiosis and multispecies anthropology. Hegarty’s work appears in journals like Medical Anthropology , American Ethnologist , and Global Public Health . He is affiliated with initiatives such as the Australian Human Rights Institute and the Center for HIV AIDS Research at Atma Jaya Catholic University.

Howard YimView profile

Researcher

• colorectal cancer
• innate immunity
• gastroenterology
• +7 more

Dr. Howard Yim is a researcher at the University of New South Wales (UNSW), where he leads the Cancer Theme at the Microbiome Research Centre. His work focuses on the intersection of microbiome research and disease pathogenesis, with particular emphasis on gastrointestinal disorders and cancer. He maintains affiliations with multiple institutions, including serving as an Adjunct Research Fellow at Monash University. Dr. Yim completed his PhD in the Department of Paediatrics and Adolescent Medicine at The University of Hong Kong, where he identified viral and host proteins contributing to infectious diseases like AIDS and tuberculosis. His subsequent postdoctoral research at the Hudson Institute of Medical Research, Monash University, focused on inflammatory disorders including inflammatory bowel diseases (IBD). His research interests center on the role of microbiota in disease pathogenesis, particularly in colorectal cancer, inflammatory bowel diseases, and male infertility. Dr. Yim investigates how microbial communities interact with host immune systems through mechanisms involving cytokines, toll-like receptors, and cellular signaling pathways. His work spans from basic science of mucosal immunity to translational applications of microbiome manipulation for disease prevention and treatment. Analysis of Dr. Yim's recent publications reveals a strong focus on the microbiome's role in cancer development and treatment, particularly colorectal and pancreatic cancers, as well as male infertility. His research shows an evolving trajectory from basic immunology of infectious diseases to clinical applications of microbiome science, with increasing emphasis on therapeutic interventions and diagnostic applications of microbial analysis. The Milstein Travel Award, International Society for Interferon and Cytokine Research, Bethesda MD, USA - 2012 Best Oral Presentation Award, the Hong Kong Society for Paediatric Immunology and Infectious Diseases, Hong Kong - 2008 Seymour and Vivian Milstein Student Research Travel Award, International Society for Interferon and Cytokine Research, Bethesda MD, USA - 2006 Dr. Yim actively supervises ILP and Honors students, Higher Degree Research Students, and PhD students. His research is supported by multiple grants including a 2023 Cancer Australia grant titled 'A Novel Probiotic as a preventive strategy for Colorectal Neoplasia' where he serves as Chief Investigator. Previous funding includes NHMRC Early Career Fellowship (2013-2015), Ron Evans Cancer Research Fellowship (2012), and multiple Research Fund for the Control of Infectious Diseases grants from the HKSAR Government. As leader of the Cancer Theme at the UNSW Microbiome Research Centre, Dr. Yim directs research on developing next-generation probiotics against colon cancer, understanding the role of virome in colon cancer pathogenesis, and investigating the microbiome's role in male infertility and pancreatic cancer treatment. His work bridges basic science and clinical applications through collaboration with clinicians and industry partners.

• Pulmonary Disease
• Epidemiology
• Air Pollution
• +3 more

Professor Guy Marks is a Conjoint Professor in the School of Clinical Medicine within the Faculty of Medicine & Health at the University of New South Wales. A distinguished respiratory physician, epidemiologist, and public health physician, he has led the Respiratory and Environmental Epidemiology group at the Woolcock Institute of Medical Research since 1997. His work bridges clinical practice, epidemiological research, and public health policy with a focus on improving lung health globally. Professor Marks' educational background includes: Bachelor of Medical Science and Bachelor of Medicine/Bachelor of Surgery (BMedSc MB BS) from the University of New South Wales PhD from the University of Sydney Membership in the Royal College of Physicians (MRCP) Fellowship of the Royal Australasian College of Physicians (FRACP) Fellowship of the Australasian Faculty of Public Health Medicine (FAFPHM) Fellowship of the Australian Academy of Health and Medical Sciences (FAHMS) Professor Marks' research program centers on lung health with specific emphasis on airways diseases, air pollution, and tuberculosis. His work spans epidemiological studies, clinical trials, and public health interventions aimed at improving respiratory health outcomes. He has a strong commitment to capacity building for lung health research, particularly in resource-limited settings. His research has significantly contributed to understanding the impact of environmental factors on respiratory diseases and developing effective strategies for tuberculosis control. Analysis of Professor Marks' recent publications (2023-2025) reveals a continued strong focus on tuberculosis epidemiology and control, air pollution health effects, and respiratory disease management. His work increasingly incorporates advanced methodologies including machine learning applications for tuberculosis detection, detailed air pollution modeling, and economic evaluations of public health interventions. Much of his research maintains a strong international perspective with significant collaborations across the Asia-Pacific region, particularly in Vietnam. Professor Marks is an active member of several professional societies: International Union Against Tuberculosis and Lung Disease Thoracic Society of Australia and New Zealand Australasian Epidemiological Association While specific details about his advising activities and grant funding are not provided in the available information, Professor Marks' extensive publication record and leadership of the Respiratory and Environmental Epidemiology group at the Woolcock Institute suggest substantial experience mentoring students and securing research funding. His work on tuberculosis prevention trials and air pollution health effects likely involves significant grant support. Professor Marks leads the Respiratory and Environmental Epidemiology group at the Woolcock Institute of Medical Research, which has been active since 1997. This research team focuses on population-level studies of respiratory diseases with particular expertise in tuberculosis epidemiology, air pollution health effects, and asthma/COPD management. The group maintains strong international collaborations, especially with researchers in Vietnam and other Asia-Pacific countries, reflecting Professor Marks' commitment to global lung health research and capacity building.

• Infectious Diseases
• Immunology
• Innate and Adaptive Immune Responses
• +4 more

Professor Carl Feng is a faculty member at the University of Sydney, affiliated with the Central Clinical School and the Department of Medicine (Infectious Diseases and Immunology). He is also a member of the Charles Perkins Centre. His research focuses on understanding host resistance mechanisms against respiratory pathogens like Mycobacterium tuberculosis and Influenza A virus, with a particular emphasis on innate and adaptive immune responses. Key areas include cytokine biology, immune regulation, and granuloma formation in tuberculosis. Recent work includes studies on spatial features in tissue, host-pathogen interactions, and vaccine development against SARS-CoV-2. Research projects under Prof. Feng explore immune correlates of protection in human subjects through international collaborations, as well as the role of interferons and signaling pathways in pathogen control. His lab investigates both basic immunological mechanisms and translational applications, such as host-directed therapies for tuberculosis treatment. Prof. Feng has supervised students including Helen CHEN (Investigating microbial exposure in host defense), Pablo CRUZ GRANADOS (Menière's Disease immune landscapes), Lucia TANG (TB granuloma formation), and Wei XIAO (Immune landscapes of mycobacterial granulomas). He holds grants from bodies like the NHMRC and NIH, focusing on granuloma architecture, immune dynamics, and tuberculosis drug development. Key contributions include discoveries about Mycobacterium tuberculosis' evasion strategies, such as d-serine production under hypoxia, and the role of interferon gamma in SARS-CoV-2 control. His work bridges cellular immunology with clinical applications, aiming to translate mechanistic insights into therapies for infectious diseases.

Heather FeagaView profile

Assistant Professor

• Ribosome Quality Control
• Microbial Physiology
• Genetic Screens
• +3 more

Heather Feaga is an Assistant Professor in the Department of Microbiology at Cornell University’s College of Agriculture and Life Sciences (CALS). She holds a PhD in Biochemistry and Molecular Microbiology from Penn State University, with postdoctoral research at Columbia University and teaching experience at CUNY/BMCC. Her research focuses on ribosome quality control mechanisms in bacteria, particularly Bacillus subtilis and pathogenic species like Bacillus anthracis. Key areas include ribosome stalling during developmental processes (sporulation/germination), translation stress responses, and antibiotic target identification. Her lab employs genetic screens, ribosome profiling, and biochemical approaches to study global translation control during spore development. Recent work highlights factors like YebC2, YfmR, and EF-P in resolving ribosome stalling and enhancing bacterial survival. Publications span topics from ribosome rescue pathways to antibiotic efficacy and bacterial pathogenesis mechanisms. Feaga’s research bridges fundamental microbiology with applied goals, aiming to identify novel antibiotic targets through understanding ribosome dynamics. Her work has been featured in journals like Molecular Cell, Journal of Bacteriology, and Scientific Reports, with ongoing studies on ribosome-associated quality control pathways and their evolutionary conservation.

Aro VelmetView profile

Associate Professor

• Modern Europe
• Transnational History
• Imperialism
• +4 more

Aro Velmet is an Associate Professor of History at the University of Southern California's Dornsife College of Letters, Arts and Sciences, where he researches modern Europe, transnational history, imperialism, colonialism, science, technology, and medicine with emphasis on technological progress in statecraft and its unintended consequences. Education: Ph.D. History and French Studies, New York University, 2017 B.A. History, University of Pennsylvania, 2010 History and Political Science, University of Tartu, 2007 Velmet investigates how utopias of technological progress serve statecraft through political technologies deployed by experts and subalterns, focusing on French colonial governance and Baltic identity formation. His acclaimed book Pasteur's Empire examines microbiology's role in colonial administration across French Africa and Asia, revealing how African politicians, Vietnamese doctors, and international regulators shaped scientific applications. His work consistently bridges science, empire, and identity politics. His recent publications demonstrate a transnational methodology spanning Estonian post-Soviet transitions, French colonial science, and Baltic memory politics, with recurring themes of imperialism, technological governance, and identity construction. The scholarship shows particular strength in connecting scientific practices to broader political frameworks across diverse geographical contexts. Awards and Honors: Member, Estonian Young Academy of Sciences, 2021 – Honorable Mention, Alf Andrew Heggoy Prize for Best Book in French Colonial History, 2020-2021 Honorable Mention, Laurence Wylie Prize for French Cultural Studies, 2020-2021 European Commission Marie Sklodowska Curie Fellowship, 2017 – 2019 Estonian Research Council, 2nd Prize, Best Dissertation in Humanities and Social Sciences, 2017-2018 Estonian Teacher’s Journal Annual Laureate, 2016-2017 Jerrold Seigel Fellowship in Intellectual History, 2016-2017 Josephine De Karman Fellowship, 2016-2017 Cultural Weekly Sirp Annual Laureate, 2014-2015 NYU Michel Beaujour Fellowship, 2014-2015 Society for Study of French History Best Article Prize, 2014-2015 Phi Beta Kappa, 2010-2011 Velmet has secured major research funding including a European Commission Marie Sklodowska Curie Fellowship (2017-2019) and Josephine De Karman Fellowship (2016-2017), enabling extensive archival work on colonial science and European history. His visiting researcher position at the University of Tartu (2021-2023) further demonstrates institutional investment in his transnational scholarship.

Christopher C. WhalenView profile

Professor

• Infectious Disease Epidemiology
• Global Health
• HIV/AIDS Research
• +3 more

Christopher C. Whalen is a Professor in the Department of Epidemiology & Biostatistics at the University of Georgia's College of Public Health , with affiliations to the Global Health Institute. He holds the Karen and Jim Holbrook Distinguished Professorship in Global Health and is a UGA Distinguished Research Professor. His research focuses on reducing mortality from infectious diseases, particularly tuberculosis (TB) and HIV in Sub-Saharan Africa, with emphasis on Uganda. He leads studies on TB control methods, HIV-TB coinfection mechanisms, and clinical care improvements. Since 1993, he has secured continuous federal grant funding for projects including household contacts studies, social network analyses, cohort studies, and clinical trials in Africa. Key Achievements: Trained over 100 graduate students via the AIDS Training and Research Program in Uganda since 1992. Developed capacity in immunology, microbiology, and data sciences in Africa. Expert in study design, causal inference, and analysis of large datasets. Advising & Grants: Serves as Principal Investigator (PI) for long-term training and research programs. Office hours: Tuesdays 11:00 a.m.–3:00 p.m. or by appointment.

Mukhlesur RahmanView profile

Associate Professor

• Pharmaceutical Chemistry
• Natural Product Chemistry
• Drug Discovery
• +5 more

Dr. Mukhlesur Rahman is an Associate Professor in Pharmaceutical and Natural Product Chemistry at the University of East London (UEL), leading the Medicines Research Group since 2020. He is also the Subject Area Lead for Drug and Chemical Sciences. He developed the BSc and MSc Pharmaceutical Science programs at UEL between 2012-2019. Education: BPharm (Hons) with First Class, MPharm with First Class, PhD. Research Interests: Bioassay-guided isolation of anti-infective compounds from plants and microbes, synthesis of bioactive natural products, NMR spectroscopy in drug discovery, ethnopharmacology, and applications of HPLC/LCMS for herbal medicine quality control. Publications: Over 30 peer-reviewed articles, book chapters, and editorials focusing on antimicrobial natural products, drug discovery, and computational phytochemistry. Recent work includes studies on anti-MRSA compounds from Citrus grandis and Ruta chalepensis, as well as synthetic drug candidates for tuberculosis and leprosy. Labs/Teams: Leads the Medicines Research Group, collaborating on drug discovery projects involving plant-derived compounds and synthetic drug design.

Abhinav AcharyaView profile

Associate Professor

• Immune Engineering
• Immunometabolism
• Drug Delivery
• +5 more

Abhinav Acharya is the Elmer Lincoln Lindseth Associate Professor of Biomedical Engineering at Case Western Reserve University's Case School of Engineering and a member of the Case Comprehensive Cancer Center. His research focuses on immune engineering and immunometabolism, leveraging biomaterials to modulate immune cell metabolism for treating cancer, autoimmune disorders, and chronic inflammation. He holds appointments in both the School of Engineering and School of Medicine, reflecting his interdisciplinary work. Education & Training: PhD in Biomedical Engineering (University of Florida) Postdoctoral Research: Georgia Institute of Technology, UC Berkeley, and University of Pittsburgh Research Interests: Dr. Acharya develops biomaterial systems to engineer immune responses via metabolic pathways. Current projects include metabolite-based polymers for cancer immunotherapy, covalent organic frameworks for immune modulation, and anti-inflammatory strategies for rheumatoid arthritis. His lab explores diseases such as melanoma, traumatic brain injury, and osteoarthritis, with a focus on translational therapies. Publications & Patents: Over 50 peer-reviewed articles and multiple patents (e.g., metabolism-targeted vaccines, wound healing polymers, and probiotic therapies). Recent work includes Nature Communications (2023), Advanced Healthcare Materials (2024), and Biomaterials Science (2022). Grants & Awards: Funding from NSF (CAREER), NIH, and industry partnerships. The lab spun out startups like Immunometabolix LLC for commercializing therapies. Labs & Teams: Runs a multidisciplinary lab with 10+ members, including PhD students, postdocs, and undergraduates. Collaborates with institutions such as Arizona State University and the University of Pittsburgh.

Celia Miralles BuilView profile

Lecturer

• History of Health
• Environmental History
• Social History of Medicine
• +7 more

Celia Miralles Buil is a Lecturer in the history of health and the environment at the Université de Strasbourg, affiliated with the SAGE laboratory (UMR 7363) within the Faculty of Medicine. She is a member of the Department of History of Life and Health Sciences (DHVS), where she conducts interdisciplinary research at the intersection of medicine, urban development, and environmental risk. Her research focuses on the social history of health in the 19th and 20th centuries, with a particular emphasis on urban environments in Iberian cities such as Lisbon and Barcelona. Key themes include infectious diseases, tuberculosis, sanitary borders, quarantine policies, and the role of architecture in public health. She explores how cities managed health and technological risks, especially in the context of migration, port activity, and environmental pollution. The trends in her publications reveal a strong focus on historical public health policy, the evolution of sanitary control mechanisms, and the transformation of urban spaces into health infrastructures. Her work often draws on comparative urban studies and integrates science and technology studies (STS) perspectives, particularly in analyzing technoscientific imaginaries and material approaches to containment. Scientific and Academic Contributions: Research Axis at SAGE: Environment, health, science and society Co-directed conference proceedings on containment and threat management in the modern world (2022) Regular presenter at international conferences including the European Association of Urban History and the European Society for the History of Science Teaching and Advising: She teaches across multiple faculties, including: Faculty of Medicine: L1SPS – transversal SHS courses on environments and infectious diseases UFR Social Sciences: L2SPS and L3SPS – Introduction to science and technology studies, History and anthropology of health-environment relations IEP (Institut d'Études Politiques): Master’s courses in Environmental Social Sciences and Sciences, Societies, Policies UFR Historical Sciences: Methodology of research in history She has collaborated on pedagogical innovations in medical humanities, including integrating visual culture into health sciences education. Laboratory and Collaborative Work: Based at SAGE (Sociétés, acteurs, gouvernement en Europe), she collaborates with scholars across France and Europe. She has worked with Frédéric Vagneron and Alexis Zimmer on medical humanities teaching initiatives and participates in networks such as the Quarantine Studies Network and EHESS seminars. Her research is deeply embedded in collaborative, interdisciplinary environments that bridge history, sociology, and public policy.

Yeon Soo BaikView profile

Researcher

• Epidemiology
• Tuberculosis Research
• HIV/AIDS Research
• +5 more

Yeon Soo Baik, PhD is an Assistant Scientist in the Department of International Health at Johns Hopkins Bloomberg School of Public Health, specializing in epidemiology with a focus on tuberculosis and HIV research. Their work spans multiple international settings including Uganda, South Africa, Botswana, and Bangladesh, addressing critical questions in infectious disease control and public health implementation. Dr. Baik completed their PhD at the University of California Los Angeles in 2019, with subsequent postdoctoral training in epidemiology. Their research expertise encompasses epidemiologic methods, translational epidemiology, molecular epidemiology, transmission and prediction modeling, longitudinal cohort analysis, and health economics specifically applied to TB/HIV research. Dr. Baik's research program demonstrates strong focus on implementation science, with numerous projects examining tuberculosis self-testing strategies in Peru, diagnostic accuracy of GeneXpert Ultra testing in South Africa, validation of clinical risk scores for early TB management in Uganda, and evaluation of short-course tuberculosis preventive therapy delivery options. They have also investigated Korea's contribution to global tuberculosis eradication efforts. Analysis of their recent publications reveals consistent focus on tuberculosis prevention and treatment among people living with HIV, with particular attention to implementation barriers, cost considerations, and patient preferences in resource-limited settings. Their work increasingly incorporates methodological approaches from health economics and behavioral science to address implementation challenges. Dr. Baik actively collaborates with researchers across multiple institutions and countries, with research output showing steady growth from 2018 to 2025. Their work has been cited in various contexts, including news outlets and social media, indicating broader impact beyond academic circles. Through their research, Dr. Baik has established expertise in quantitative epidemiology that extends beyond TB/HIV to include Chagas disease, respiratory and neurological diseases, and sexually transmitted infections, demonstrating methodological versatility in addressing diverse public health challenges.